214 related articles for article (PubMed ID: 10411105)
1. Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.
Dolo V; D'Ascenzo S; Violini S; Pompucci L; Festuccia C; Ginestra A; Vittorelli ML; Canevari S; Pavan A
Clin Exp Metastasis; 1999 Mar; 17(2):131-40. PubMed ID: 10411105
[TBL] [Abstract][Full Text] [Related]
2. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles.
Graves LE; Ariztia EV; Navari JR; Matzel HJ; Stack MS; Fishman DA
Cancer Res; 2004 Oct; 64(19):7045-9. PubMed ID: 15466198
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.
Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML
J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045
[TBL] [Abstract][Full Text] [Related]
4. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2.
Young TN; Rodriguez GC; Rinehart AR; Bast RC; Pizzo SV; Stack MS
Gynecol Oncol; 1996 Jul; 62(1):89-99. PubMed ID: 8690299
[TBL] [Abstract][Full Text] [Related]
5. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells.
Millimaggi D; Festuccia C; Angelucci A; D'Ascenzo S; Rucci N; Flati S; Bologna M; Teti A; Pavan A; Dolo V
Int J Oncol; 2006 Apr; 28(4):909-14. PubMed ID: 16525640
[TBL] [Abstract][Full Text] [Related]
7. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells.
Fishman DA; Bafetti LM; Banionis S; Kearns AS; Chilukuri K; Stack MS
Cancer; 1997 Oct; 80(8):1457-63. PubMed ID: 9338470
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
9. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.
Dolo V; Ginestra A; Cassarà D; Violini S; Lucania G; Torrisi MR; Nagase H; Canevari S; Pavan A; Vittorelli ML
Cancer Res; 1998 Oct; 58(19):4468-74. PubMed ID: 9766680
[TBL] [Abstract][Full Text] [Related]
10. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.
Ginestra A; La Placa MD; Saladino F; Cassarà D; Nagase H; Vittorelli ML
Anticancer Res; 1998; 18(5A):3433-7. PubMed ID: 9858920
[TBL] [Abstract][Full Text] [Related]
11. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
Meade-Tollin LC; Way D; Witte MH
Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.
Ahmed N; Pansino F; Clyde R; Murthi P; Quinn MA; Rice GE; Agrez MV; Mok S; Baker MS
Carcinogenesis; 2002 Feb; 23(2):237-44. PubMed ID: 11872628
[TBL] [Abstract][Full Text] [Related]
13. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.
Miyagi E; Yasumitsu H; Hirahara F; Minaguchi H; Koshikawa N; Miyazaki K; Umeda M
Jpn J Cancer Res; 1995 Jun; 86(6):568-76. PubMed ID: 7622422
[TBL] [Abstract][Full Text] [Related]
14. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
[TBL] [Abstract][Full Text] [Related]
15. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells.
Rosanò L; Varmi M; Salani D; Di Castro V; Spinella F; Natali PG; Bagnato A
Cancer Res; 2001 Nov; 61(22):8340-6. PubMed ID: 11719468
[TBL] [Abstract][Full Text] [Related]
18. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression.
Murthi P; Barker G; Nowell CJ; Rice GE; Baker MS; Kalionis B; Quinn MA
Gynecol Oncol; 2004 Jan; 92(1):80-8. PubMed ID: 14751142
[TBL] [Abstract][Full Text] [Related]
20. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
